D-0723-2022 Class III Terminated

Recalled by Olympia Compounding Pharmacy Dba Olympia Pharmacy — Orlando, FL

FDA drug recall D-0723-2022 was initiated by Olympia Compounding Pharmacy Dba Olympia Pharmacy on Mar 8, 2022 and is designated Class III. Reason for recall: Sub Potent The recall status is terminated (terminated Oct 4, 2023). Affected quantity: 1613 vials.

Recall Details

Product Type
Drugs
Report Date
Mar 30, 2022
Initiation Date
Mar 8, 2022
Termination Date
Oct 4, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1613 vials

Product Description

Hydroxocobalamin B12 1mg/mL, Multi-Dose 30 mL vial, Each ML contains: 0.82% Sodium Chloride USP, 0.9% Benzyl Alcohol NF, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals Conroy Rd., Ste. 155, Orlando, FL 32835 NDC 73198-0080-30

Reason for Recall

Sub Potent

Distribution Pattern

Nationwide in the USA including Puerto Rico.

Code Information

Lot: E47025 Exp. 5/21/22

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0723-2022
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.